- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New Diabetes Guidelines Have It Both Ways
A new guideline calls for a tailored approach to treating type 2 diabetes while maintaining the use of an algorithm-based model, researchers said.
The new recommendations from the American Association of Clinical Endocrinologists (AACE) offer an algorithm that involves every FDA approved class of medications for managing hyperglycemia, while still suggesting consideration of individual patient characteristics such as age and comorbidities, Alan Garber, MD, PhD, of Baylor College of Medicine in Houston, and colleagues reported in Endocrine Practice.
"The majority of patients aren't reaching goal," Garber told MedPage Today. "We think a more assertive recommendation of treatments will help physicians get patients to goal and avoid the pitfalls of certain medications."
Read the full story here: http://bit.ly/ZIBaoW
Source: MedPageToday.com
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
